Seven months into the pandemic, the U.S. needs to rethink its approach to testing for COVID-19, experts say, by shifting to cheaper tests that can return results in less than an hour, potentially finding people when they are most infectious and containing outbreaks before they explode.
The Food and Drug Administration (FDA), however, appears reluctant to approve those tests for sale in the U.S. because they are typically less accurate or unable to detect small amounts of virus compared to the gold standard, high-sensitivity lab tests the U.S. has been...
Read more about The Hill: "US urged to consider cheaper, faster COVID-19 tests to contain outbreaks"